GBNHF
AcquiredGBNHF — Post-Mortem
Greenbrook TMS Inc., previously trading under the symbol GBNHF, was a notable player in the mental health technology market, specializing in transcranial magnetic stimulation for depression. The company's trajectory shifted dramatically in late 2024, culminating in an acquisition by Neuronetics, Inc. on December 9, 2024. Under a plan of arrangement, shareholders received 0.01021 shares of Neuronetics for each Greenbrook share, effectively terminating Greenbrook's independent listing. Despite its innovative offerings, the company faced financial difficulties, necessitating unsecured debt financing prior to the acquisition. The transaction highlighted the increasingly competitive landscape of mental health services and the pressures that smaller firms face, particularly in securing capital.
Greenbrook TMS Inc. was acquired by Neuronetics, Inc. in December 2024, effectively ceasing its independent operations and leading to the delisting of its shares.
Could I Have Seen This Coming?
No structured pre-delisting signals found in our records. Absence of signals does not imply absence of risk.
Post-Mortem Analysis
Five-section narrative grounded in primary filings and contemporaneous reporting.
Origin
Greenbrook was established to address gaps in mental health treatment through innovative technologies. It focused on providing accessible, non-invasive therapy options, particularly for major depressive disorder.
Peak
Greenbrook's operations peaked with its growing network of treatment centers, offering robust revenue potential drawn from an increasing demand for mental health solutions. Initial public offerings and market entry were viewed positively by investors.
Turning Point
The company's financial health began to deteriorate, evidenced by its reliance on promissory notes for immediate liquidity needs which signaled operational challenges. The SEC filing indicated a significant conversion of debt into equity right before the acquisition.
End
With the completion of the acquisition on December 9, 2024, Greenbrook was wholly absorbed by Neuronetics, marking the end of its status as a publicly listed company.
Impact
The acquisition resulted in Greenbrook ceasing to exist as an independent entity and its shares being delisted from trading. As a result, shareholders received Neuronetics shares in exchange for their Greenbrook holdings, indicating a complete transfer of ownership and resources to Neuronetics.
Lessons for Today's Investors
Transferable patterns identified from this case, written as research-report observations.
- 1
The necessity for clear financial visibility: Investors should assess a company's financial structure and dependencies to avoid unexpected declines in value.
- 2
The importance of strategic partnerships: Collaborations can provide financial backing and operational synergies that may be crucial in turbulent times.
- 3
Market pressures can dictate company fates: Smaller firms in specialized sectors should be vigilant about market dynamics and competitive positioning.
Frequently Asked Questions
What happened to Greenbrook TMS Inc.?
Why did Greenbrook TMS Inc. cease operations?
What did shareholders receive during the acquisition?
What was the outcome of the acquisition for Greenbrook's operational status?
When was the acquisition of Greenbrook TMS Inc. finalized?
Source Filings
Every fact on this page is anchored to a primary SEC filing or regulatory record. Open any source to verify against the original document.
SEC EDGAR · Form 8-KFiled Dec 10, 2024
On December 5, 2024, Greenbrook TMS Inc. entered into unsecured promissory notes with Madryn Health Partners II (Cayman Master), LP and Madryn Health Partners II, LP for an aggregate principal amount of US$1,500,000.
SEC EDGAR · Form 8-KFiled Dec 10, 2024
The promissory notes issued by Greenbrook TMS Inc. mature on December 31, 2024, or earlier depending on specified conditions.
SEC EDGAR · Form 8-KFiled Dec 10, 2024
Greenbrook TMS Inc. and Neuronetics, Inc. completed a transaction on December 9, 2024, where Neuronetics acquired all issued and outstanding common shares of Greenbrook.
SEC EDGAR · Form 8-KFiled Dec 10, 2024
Effective December 9, 2024, following the acquisition, Greenbrook TMS Inc. became an indirect, wholly owned subsidiary of Neuronetics.
SEC EDGAR · Form 8-KFiled Dec 10, 2024
On December 10, 2024, Greenbrook TMS Inc. and Neuronetics issued a joint press release announcing the completion of the acquisition.
SEC EDGAR · Form 8-KFiled Dec 10, 2024
Prior to the acquisition, on December 9, 2024, Greenbrook converted approximately US$128 million of debt into shares, resulting in 2,309,453,605 shares allocated to Madryn and its affiliates.
SEC EDGAR · Form 8-KFiled Dec 10, 2024
After the debt conversion, Madryn and its affiliates owned approximately 95.8% of the issued and outstanding Greenbrook Shares.
SEC EDGAR · Form 25Filed Apr 1, 2024
Removed from listing - SEC Form 25 filed.
Narrative sections on this page are AI-assisted summaries of the filings linked above. All content is reviewed against primary sources; if you find an error, the canonical record is always the linked filing.
Categories:
Industries:
Tags:
Related tickers: